松龄血脉康胶囊治疗原发性高血压病的效果观察

Clinical observation of songlingxuemaikang in the treatment of primary hypertension

目的观察松龄血脉康胶囊治疗原发性高血压病1级患者的降压效果。方法选择2009-09~2012-06该院门诊首次确诊的原发性高血压病1级患者45例,给予松龄血脉康胶囊治疗并观察疗效。结果45例患者服药治疗后显效27例,有效18例,总有效率为100%。结论松龄血脉康胶囊降压作用确切,且安全无毒副作用,值得临床推广应用。

Objective To observe the antihypertensive effect of songlingxuemaikang capsule in the treatment of patients with grade 1 hypertension.Methods Forty-five patients with primary hypertension first diagnosed in clinic of the Third People＇s Hospital of Zhengzhou from September 2009 to June 2012 were treated with songlingxuemaikang capsule and the curative effects were observed.Results Among 45 patients,marked-effect was found in 27 patients,good in 18 patients.The total effective rate was 100%.Conclusion The antihypertensive effect of songlingxuemaikang is good,and it is safe and worthy of clinical promotion.